Presentation on theme: "West Coast University Solomon Tan, MSN/Ed. RN-BC, PHN 2011 Schizophrenia Chapter 15."— Presentation transcript:
West Coast University Solomon Tan, MSN/Ed. RN-BC, PHN 2011 Schizophrenia Chapter 15
Eugen Bleuler’s 4 A’s of Schizophrenia Affect Associative looseness Autism Ambivalence
Epidemiology Lifetime prevalence of schizophrenia 1% worldwide Average onset is late teens to early twenties, but can be as late as mid-fifties 30% to 40% relapse rate in the first year Life expectancy is shortened because of suicide No difference related to –Race, Social status, Culture
Comorbidity Substance abuse disorders –Nicotine dependence Anxiety, depression, and suicide Physical health or illness Polydipsia
Etiology Continued Psychological and environmental factors –Prenatal stressors –Psychological stressors –Environmental stressors
Signs and Symptoms Language and communication disturbances Thought disturbances Perception disturbances Affect disturbances Motor behavior disturbances Self-identity disturbances
Features of Schizophrenia Progression varies from one client to another –Exacerbations and remissions –Chronic but stable –Progressive deterioration DSM-IV-TR Diagnosis –Symptoms present at least 6 months –Active-phase symptoms present at least 1 month –Symptoms are defined as positive and negative
Phases of Schizophrenia Phase I – Acute –Onset or exacerbation of symptoms Phase II – Stabilization –Symptoms diminishing –Movement towards previous level of functioning Phase III – Maintenance –At or near baseline functioning
Assessment During the prepsychotic phase General assessment –Positive symptoms (Excess or distorted) –Negative symptoms (Deficit) –Cognitive symptoms –Affective symptoms
Positive Symptoms Alterations in thinking –Delusions are false, fixed beliefs Persecutory, Referential Somatic, Religious, Substitution, Thought Insertion and/or Broadcasting Nihilistic, Grandiose –Concrete thinking is an inability to think abstractly. Indecisiveness, lack of problem solving skills, Concreteness, thought blocking, perseveration
Positive Symptoms Continued Alterations in speech –Neologisms –Echolalia –Echopraxia –Clang associations –Word salad –Loose Association
Positive Symptoms Continued Alterations in perception –Depersonalization –Derealization –Hallucinations Auditory hallucinations Command hallucinations Visual hallucinations –Boundary impairment –Negativism –Impaired impulse control
Negative Symptoms (5A’s) –Affect Flat, Blunted, Inappropriate, Bizarre –Apathy Indifference towards people, events, activities and learning. –Alogia Poverty of speech –Avolition Inability to pursue and persist in goal-directed activities. –Anhedonia Inability to experience pleasure.
Review Question A patient with schizophrenia says, “There are worms under my skin eating the hair follicles.” How would you classify this assessment finding? a.Positive symptom b.Negative symptom c.Cognitive symptom d.Depressive symptom
Review Question The nurse is documenting in the multidisciplinary treatment plan. Which assessment data depicts positive symptoms of schizophrenia? –A. “I use to like going to the movies and spending time with my family but rather be alone.” –B. “I don’t want to go to group.” Lack motivation and affect appear Blunted. –C. “I can’t sit still and I feel like I want to jump out of my skin.” –D. “There are cameras in the ceiling and the voices are whispering to me.”
Subtypes of Schizophrenia Paranoid type Disorganized type Catatonic type Undifferentiated type Residual Type
Subtypes of Schizophrenia - continued Paranoid Type –Delusions Persecutory and grandiose Somatic or religious –Hallucinations Delusions link with a hallucination Disorganized Type Disorganized speech, behavior, appearance Flat or inappropriate affect Fragmented hallucinations and delusions Most severe form of schizophrenia
Specific Interventions for Paranoid and Disorganized Schizophrenia Communication guidelines Self-care needs Milieu needs
Subtypes of Schizophrenia - continued Catatonic type –Psychomotor retardation and stupor Waxy flexibility Mutism –Extreme psychomotor agitation Echolalia Echopraxia
Subtypes of Schizophrenia - continued Undifferentiated type –Active psychotic state (Positive & Negative symptoms) –Lacks symptoms of other subtypes Residual type –Active-phase symptoms no longer present –No prominent positive symptoms –Negative symptoms present
Other Psychotic Disorders Schizophreniform disorder Schizoaffective disorder Delusional disorder Brief psychotic disorder Shared Psychotic Disorder (Folie à Deux) Induced or Secondary Psychosis
Assessment Guidelines 1. Any medical problems 2. Abuse of or dependence on alcohol or drugs 3. Risk to self or others 4.Command hallucinations 5. Belief system 6. Suicide risk
Assessment Guidelines Continued 7. Ability to ensure self-safety 8.Co-occurring disorders 9. Medications 10. Presence and severity of positive and negative symptoms 11. Patient’s insight into illness 12. Family’s knowledge of patient’s illness and symptoms
Potential Nursing Diagnoses Positive symptoms –Risk for violence –Disturbed sensory perception –Risk for self-directed or other-directed violence –Disturbed thought processes Negative symptoms –Social isolation –Chronic low self-esteem –Altered health maintenance –Ineffective coping –Impaired verbal communication
Outcomes Identification Phase I - Acute Patient safety and medical stabilization Phase II - Stabilization –Adhere to treatment –Stabilize medications –Control or cope with symptoms Phase III - Maintenance –Maintain achievement –Prevent relapse –Achieve independence, satisfactory quality of life
Planning Phase I – Acute –Best strategies to ensure patient safety and provide symptom stabilization Phase II – Stabilization Phase III – Maintenance –Provide patient and family education –Relapse prevention skills are vital
Interventions Acute Phase –Psychiatric, medical, and neurological evaluation –Psychopharmacological treatment –Support, psychoeducation, and guidance –Supervision and limit setting in the milieu
Interventions Continued Stabilization and Maintenance Phase –Milieu management –Activities and groups –Safety –Counseling and communication techniques
Interventions Continued Stabilization and Maintenance Phase, continued –Hallucinations –Delusions –Associative looseness –Health teaching and health promotion
Nursing Implications: Supporting Families Family needs vary with degree of illness and involvement in client’s care –Education –Financial support –Psychosocial support –Advocacy
Nursing Implications: Supporting Families - continued Schizophrenia is a “family illness.” Family members need to be involved. Educate family about –Medication –Illness –Relapse prevention Nurse assists family by –Identifying community agencies/groups for family members –Advocating for rights
General Nursing Intervention Promote Safety and a Safe Environment Promote Congruent Emotional Response Promote Social Interaction and Activity Intervene with Hallucinations and Delusions Preventing Relapse Promoting adherence with medication regimen Assist with grooming and hygiene Promote Family Understanding and Involvement
Review Question The client informs you that the CIA monitoring his every move to find evidence that he killed someone. Which response by the nurse is therapeutic for the client?
Review Answers A. "I will make sure that the security guard will monitor your room.” B. "Don't worry you are safe here, the CIA can't enter the hospital.” C. "You seem fearful for your safety, but you are safe here.” D. "Why do you think the CIA is following you, who did you kill?”
Psychopharmacology Prior to the 1950s: focus on behavioral interventions and sedatives Mid-fifties: Introduction of the first antipsychotic medication chlorpromazine (Thorazine) Psychiatric medications allow for the improve imbalances of neurotransmitters. Goal is to treat quickly so disease does not progress. Clients may initially be resistant to medications.
Goals of Antipsychotics Positive Effects –Allowed release of clients from inpatient hospital to treatment in the community –Manage the symptoms such as delusional thinking, hallucinations, confusion, motor agitation, motor retardation, blunted affect, bizarre behavior, social withdrawal and agitation. Alleviation of the symptoms, often improving: –Ability to think logically –Ability to function in one’s daily life –Ability to function in relationships
Negative Effects of Antipsychotics Negative Effects –Frightening and life threatening side effects –Potential interactions with other medications and substances –Possible need to cope with the realization of having a chronic illness
All current antipsychotics work on at least one of these neurotransmitters: Dopamine Serotonin
Antipsychotics Typical (Conventional) –Block dopamine receptors at 70% to 80% occupancy to be effective. Exptrapyramidal Side Effects (EPSEs) occur at occupancy > 80 Typical = Tardive Dyskinesia (TD) –5.4% vs 0.8% atypicals
Atypical Antipsychotics Treat both positive and negative symptoms Fewer extrapyramidal side effects (EPSs) or tardive dyskinesia Reduced affinity for dopamine (D 2 ) receptors Affinity for serotonin receptors D 2 antagonist + Serotonin receptor antagonist Disadvantage – tendency to cause significant weight gain
Atypical Antipsychotics Continued –Clozapine (Clozaril) (6.25 – 900 mg/d) Side effects: 5% risk of seizures, agranulocytosis, weight gain, hypersalivation, anticholinergic –Olanzapine (Zyprexa, Zyprexa Zydis, Zyprexa Relprevv) (5 – 20 mg/d) Side effects: Weight gain, diabetes, sedation, bankruptcy 20mg/day = $925/month –Paliperidone (Invega) (3 – 12 mg/d) –Quetiapine (Seroquel) (150 – 600 mg/d) Side effects: sedation, weight gain, restless leg syndrome –Risperidone (Risperdal, Risperdal M-Tab) (2 – 6 mg/d) (Increase Prolactin)
Atypical Antipsychotics Continued –Ziprasidone (Geodon) ( 40 – 160 mg/d) Side effects: QTc prolongation, minimal sedation Administer with food for improve efficacy –Aripiprazole (Abilify) (15 – 30 mg/d) Side effects: akathisia, insomnia/sedation, maybe less weight gain –Asenapine (Saphris) (5 – 10 mg/d) Sublingual –Iloperidone (Fanapt) (12 – 24mg/d) –Lurasidone HCL (Latuda) (40 – 80 mg/d)
Long-Acting Injectables Depot Therapy –Risperidone Consta (Risperdal Consta) Q2 Weeks –Paliperidone Sustenna (Invega Sustena) Q 4 weeks –Zyprexa Relprevv (Q2 or Q4 weeks depending on the dose) Monitor for 3 hours after injection
Antiadrenergic Effect: Orthostatic Hypotension Take the client’s blood pressure in a supine position and then in a standing position. Caution clients to rise slowly from a supine position.
Extrapyramidal Side Effects Interventions Acute dystonia –anticholinergics Akathisia –anticholinergics but not always responsive Pseudoparkinsonism –anticholinergics Tardive dyskinesia – –Abnormal Involuntary Movement Scale (AIMS)
Dystonia Occurs usually within 48 hours of initiation of the medication Involves bizarre and severe muscle contractions Can be painful and frightening Characterized by odd posturing and strange facial expressions: –Torticollis –Opisthotonus –Laryngospasm –Oculogyric
Drug-induced Parkinsonism Usually occurs after 3 or more weeks of treatment Characterized by: –Cogwheel rigidity –Tremors at rest –Rhythmic oscillations of the extremities –Pill rolling movement of the fingers –Bradykinesia –Postural Changes
Akathisia Usually occurs after 3 or more weeks of treatment Subjectively experienced as desire or need to move Described as feeling like jumping out of the skin Mild: a vague feeling of apprehension or irritability Severe: an inability to sit still, resulting in rocking, running, or agitated dancing
Tardive Dyskinesia Usually occurs late in the course of long-term treatment Characterized by abnormal involuntary movements (lip smacking, tongue protrusion, foot tapping) Often irreversible Prophylactic use of vitamin E and Omega-3 FFA Avoid typical antipsychotics Abnormal Involuntary Movement Scale
Autonomic Nervous System Effects: Anticholinergic Side Effects Dry mouth Blurred vision Constipation Urinary retention Tachycardia
Interventions for Anticholenergic Side Effects –Ice chips, hard candy –Eye drops –Fiber diet, exercise –Increase fluid intake –Catheterization
Potentially Dangerous Responses to Antipsychotics Neuroleptic malignant syndrome (NMS) –Typically occurs in the first 2 weeks of treatment or when the dose is increased –Hold the medication, notify the physician, and begin supportive treatments. –Symptoms: muscle rigidity, tachycardia, hyperpyrexia, altered consciousness, tremors and diaphoresis
Neuroleptic malignant syndrome (NMS) Risk Factors –Dehydration –Agitation or catatonia –Increase dose of neuroleptic –Withdrawal from anti-parkinson medication –Long acting or depot medication Pharmacologic treatment –Antipyretics –Muscle relaxant –Dopamine receptor agonist
Potentially Dangerous Responses to Antipsychotics Agranulocytosis –Early symptoms: beginning signs of infection –White blood cells are routinely monitored in clients taking clozapine (Clozaril).
Other Central Nervous System Effects Sedation Lowering of the seizure threshold: –Observe clients with seizures disorders carefully when treatment is initiated.
Cardiac Effects Some antipychotics may contribute to prolongation of the QTc interval and lead to arrhythmias. –An EKG can identify those at risk.
Endocrine Effects Hyperprolactinemia may cause: –Oligomenorrhea or amenorrhea in women –Galactorrhea in women and rarely in men –Osteoporosis if prolonged Impotence in males may occur. Diabetes –Monitor blood glucose levels.
Weight Gain Monitor weight Teach about diet and exercise Weight gain may contribute to physical as well as psychosocial stressors
Adjuncts to Antipsychotic Drug Therapy Antidepressants Antimanic agents
Advanced Practice Interventions Psychotherapy Cognitive-behavioral therapy (CBT) Group therapy Medication Social skills training Cognitive remediation Family therapy